-
Loading metrics
Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility
- Jeffrey W. Craig,
- Michael J. Mina,
- Jennifer L. Crombie,
- Ann S. LaCasce,
- David M. Weinstock,
- Geraldine S. Pinkus,
- Olga Pozdnyakova
x
- Published: July 18, 2018
- https://doi.org/10.1371/journal.pone.0199708